Showing results 15 to 19 of 19
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Lamivudine for chronic hepatitis B [2] (multiple letters) Journal:New England Journal of Medicine | 1998 | ||
Modelling NAFLD disease burden in four Asian regions—2019-2030 Journal:Alimentary Pharmacology and Therapeutics | 2020 | ||
Nucleos(t)ide analogue withdrawal in chronic hepatitis B patients leads to limited sustained remission in the absence of HBsAg loss: results from the RETRACT-B study. Oral Presentation. Proceeding/Conference:The Liver Meeting 2021 (AASLD 2021), 12-15 November 2021. Hepatology | 2021 | ||
2021 | |||
A one-year trial of lamivudine for chronic hepatitis B Journal:New England Journal of Medicine | 1998 |